The chance of OS was numerically higher in the RIF group than in the ATO group, although the result did not reach statistical significance (pooled OR of 5.48, 95% CI: 0.91-32.86, P = .06, I 2 = 0%; Figure 3A ). 7 , 8 , 10 Similar result was observed for the chance of EFS that was numerically higher among patients who received RIF but without statistical significance (pooled OR: 2.87, 95% CI: 0.73-11.33, P = .13, I 2 = 0%; Figure 3
← all excerpts
Efficacy and the Adverse Effects of Oral Versus Intravenous Arsenic for Acute Promyelocytic Leukemia: A Meta-Analysis of Randomized-Controlled Studies.
1
0.0600
0.0600